title: Double versus standard loading dose of ticagrelor: onset of antiplatelet action in patients with STEMI undergoing primary PCI.
authors.forename: Dimitrios
authors.initials: D
authors.lastname: Alexopoulos
authors.forename: Vassilios
authors.initials: V
authors.lastname: Gkizas
authors.forename: Sotirios
authors.initials: S
authors.lastname: Patsilinakos
authors.forename: Ioanna
authors.initials: I
authors.lastname: Xanthopoulou
authors.forename: Christos
authors.initials: C
authors.lastname: Angelidis
authors.forename: Prodromos
authors.initials: P
authors.lastname: Anthopoulos
authors.forename: George
authors.initials: G
authors.lastname: Makris
authors.forename: Angelos
authors.initials: A
authors.lastname: Perperis
authors.forename: Stavros
authors.initials: S
authors.lastname: Karanikas
authors.forename: Nikolaos
authors.initials: N
authors.lastname: Koutsogiannis
authors.forename: Periklis
authors.initials: P
authors.lastname: Davlouros
authors.forename: Spyridon
authors.initials: S
authors.lastname: Deftereos
authors.forename: John
authors.initials: J
authors.lastname: Chiladakis
authors.forename: George
authors.initials: G
authors.lastname: Hahalis
mesh_terms: D000241:Adenosine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000368:Aged; D001792:Blood Platelets / Q000187:drug effects*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy / Q000601:surgery*; D062645:Percutaneous Coronary Intervention / Q000379:methods*; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage* / Q000627:therapeutic use; D011446:Prospective Studies; D058921:Purinergic P2Y Receptor Antagonists / Q000008:administration & dosage* / Q000627:therapeutic use; D000077486:Ticagrelor; D016896:Treatment Outcome
chemical_list: D010975:Platelet Aggregation Inhibitors; D058921:Purinergic P2Y Receptor Antagonists; D000077486:Ticagrelor; D000241:Adenosine